Trade media property Contract Pharma highlighted Ascendia Pharma in a special video profile recorded at the Contracting and Outsourcing Conference. In the video, Robert Bloder, board advisor and chief business officer of Ascendia, explains that the company is a CDMO that mainly focuses on poorly soluble molecules, specifically in the nanotechnology space.
Bob explains the unique position Ascendia has in the market. He explains the company’s three patented technologies (AmorSol, EmulSol, and NanoSol), the experienced and committed team, and a culture built on three pillars – brilliant technology, excellent service, and trust.
Watch the video below to learn more.